These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15588075)

  • 21. Bradykinin B1 receptor antagonists: a patent update 2009 - 2012.
    Bozó É; Éles J; Keserű GM
    Expert Opin Ther Pat; 2012 Dec; 22(12):1443-52. PubMed ID: 23033970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, analgesic and anti-inflammatory evaluation of some new 3H-quinazolin-4-one derivatives.
    Alafeefy AM; Kadi AA; El-Azab AS; Abdel-Hamide SG; Daba MH
    Arch Pharm (Weinheim); 2008 Jun; 341(6):377-85. PubMed ID: 18535995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.
    Swanson DM; Dubin AE; Shah C; Nasser N; Chang L; Dax SL; Jetter M; Breitenbucher JG; Liu C; Mazur C; Lord B; Gonzales L; Hoey K; Rizzolio M; Bogenstaetter M; Codd EE; Lee DH; Zhang SP; Chaplan SR; Carruthers NI
    J Med Chem; 2005 Mar; 48(6):1857-72. PubMed ID: 15771431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
    Huang H; Player MR
    J Med Chem; 2010 Aug; 53(15):5383-99. PubMed ID: 20369879
    [No Abstract]   [Full Text] [Related]  

  • 25. 1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.
    Guo Q; Chandrasekhar J; Ihle D; Wustrow DJ; Chenard BL; Krause JE; Hutchison A; Alderman D; Cheng C; Cortright D; Broom D; Kershaw MT; Simmermacher-Mayer J; Peng Y; Hodgetts KJ
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5027-31. PubMed ID: 18752949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.
    Dressen D; Garofalo AW; Hawkinson J; Hom D; Jagodzinski J; Marugg JL; Neitzel ML; Pleiss MA; Szoke B; Tung JS; Wone DW; Wu J; Zhang H
    J Med Chem; 2007 Oct; 50(21):5161-7. PubMed ID: 17880055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromenones as potent bradykinin B1 antagonists.
    Bryan MC; Biswas K; Peterkin TA; Rzasa RM; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    Bioorg Med Chem Lett; 2012 Jan; 22(1):619-22. PubMed ID: 22088753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents.
    Radwan MA; Ragab EA; Sabry NM; El-Shenawy SM
    Bioorg Med Chem; 2007 Jun; 15(11):3832-41. PubMed ID: 17395469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
    Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepines as potent and selective bradykinin B1 antagonists.
    Wood MR; Kim JJ; Han W; Dorsey BD; Homnick CF; DiPardo RM; Kuduk SD; MacNeil T; Murphy KL; Lis EV; Ransom RW; Stump GL; Lynch JJ; O'Malley SS; Miller PJ; Chen TB; Harrell CM; Chang RS; Sandhu P; Ellis JD; Bondiskey PJ; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2003 May; 46(10):1803-6. PubMed ID: 12723943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory pain in the rabbit: a new, efficient method for measuring mechanical hyperalgesia in the hind paw.
    Dong H; Sun H; Magal E; Ding X; Kumar GN; Chen JJ; Johnson EJ; Manning BH
    J Neurosci Methods; 2008 Feb; 168(1):76-87. PubMed ID: 18022246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.
    Giblin GM; Bit RA; Brown SH; Chaignot HM; Chowdhury A; Chessell IP; Clayton NM; Coleman T; Hall A; Hammond B; Hurst DN; Michel AD; Naylor A; Novelli R; Scoccitti T; Spalding D; Tang SP; Wilson AW; Wilson R
    Bioorg Med Chem Lett; 2007 Jan; 17(2):385-9. PubMed ID: 17084082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor.
    Fox A; Kaur S; Li B; Panesar M; Saha U; Davis C; Dragoni I; Colley S; Ritchie T; Bevan S; Burgess G; McIntyre P
    Br J Pharmacol; 2005 Apr; 144(7):889-99. PubMed ID: 15685199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory and analgesic activities of 1-[2-(substituted benzothiazole)]-1,3-diethyl-4-aryl guanidines.
    Naik PR; Pandeya SN; Pandey A
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):189-90. PubMed ID: 9062820
    [No Abstract]   [Full Text] [Related]  

  • 36. Bradykinin B1 receptor antagonists as novel analgesics: a retrospective of selected medicinal chemistry developments.
    Kuduk SD; Bock MG
    Curr Top Med Chem; 2008; 8(16):1420-30. PubMed ID: 18991728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of biologically active N-methyl derivatives of amidines and cyclized five-membered products of amidines with oxalyl chloride.
    Sondhi SM; Dinodia M; Jain S; Kumar A
    Eur J Med Chem; 2008 Dec; 43(12):2824-30. PubMed ID: 18022734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
    Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
    Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of 2(3H)-furanones and 2(3H)-pyrrolones, combining analgesic and anti-inflammatory properties with reduced gastrointestinal toxicity and lipid peroxidation.
    Alam MM; Husain A; Hasan SM; Suruchi ; Anwer T
    Eur J Med Chem; 2009 Jun; 44(6):2636-42. PubMed ID: 19059680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents.
    Biava M; Porretta GC; Poce G; Supino S; Manetti F; Forli S; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Makovec F; Giordani A; Anzellotti P; Cirilli R; Ferretti R; Gallinella B; La Torre F; Anzini M; Patrignani P
    Bioorg Med Chem; 2008 Sep; 16(17):8072-81. PubMed ID: 18752957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.